Eupnea and gasping in vivo are facilitated by the activation of 5-HT 2A receptors
Eupnea and gasping in infancy depend on central nervous system (CNS) serotonin (5-hydroxytryptamine; 5-HT). Although previous in vitro preparations have provided some evidence that 5-HT acts through type 2 A receptors (5-HT ) to facilitate eupnea and gasping, here the hypothesis addressed is that 5-...
Gespeichert in:
Veröffentlicht in: | Journal of neurophysiology 2021-05, Vol.125 (5), p.1543-1551 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Eupnea and gasping in infancy depend on central nervous system (CNS) serotonin (5-hydroxytryptamine; 5-HT). Although previous in vitro preparations have provided some evidence that 5-HT acts through type 2 A receptors (5-HT
) to facilitate eupnea and gasping, here the hypothesis addressed is that 5-HT
receptor activation is necessary for eupnea and the proper generation of gasping in vivo. To test this, we administered 2,5-dimethoxy-4-iodoamphetamine (DOI; 0.25 mg/kg i.p.), a 5-HT
agonist, 8-hydroxy-2-(di-
-propylamino)tetralin (8-OH-DPAT; 0.25 mg/kg i.p.), a 5-HT
agonist, or vehicle (saline) to 7-9-day-old tryptophan hydroxylase 2 knockout (TPH2
) mice. A second experiment assessed the effect of MDL-11,939 (MDL; 10 mg/kg i.p.), the specific 5-HT
antagonist, or vehicle (DMSO) on the gasping of wild-type (TPH2
) animals. Drugs were given 15 min prior to five episodes of severe hypoxia that elicited gasping. TPH2
breathed more slowly but had the same V̇e and V̇e/V̇o
compared with TPH2
. As previously reported, the gasping of TPH2
was significantly delayed (
< 0.001) and occurred at a significantly lower frequency compared with TPH2
(
= 0.04). For both genotypes, DOI hastened eupneic frequency but had no effect on V̇e or V̇e/V̇o
. The gasping of TPH2
, although unaffected by 8-OH-DPAT, was indistinguishable from the gasping of TPH2
following DOI. In TPH2
, application of MDL led to hypoventilation (
= 0.01), a delay in the appearance of gasping (
= 0.005), and reduced gasp frequency (
= 0.05). These data show that, in vivo, 5-HT
receptors facilitate both eupnea and gasping. As has been shown in vitro, 5-HT
probably promotes gasping by exciting hypoxia-resistant pacemaker neurons.
Previous in vitro studies suggest that 5-HT
receptors contribute to eupnea and are necessary for fictive gasping. The current study shows that the impaired gasping displayed by neonatal TPH2
mice, deficient in CNS serotonin, is restored by 5-HT
receptor activation. Following 5-HT
blockade, wild-type mice hypoventilated and their gasping resembled that of TPH2
mice. This study shows that both eupnea and gasping in vivo rely on the activation of 5-HT
receptors. |
---|---|
ISSN: | 0022-3077 1522-1598 |
DOI: | 10.1152/jn.00088.2021 |